Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CTKB | AZN | AMGN | GILD | BMY |
| Company | Cytek Biosciences Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 4.68 | 201.44 | 346.63 | 138.61 | 57.67 |
| High | 4.69 | 201.80 | 351.25 | 140.27 | 58.93 |
| Low | 4.59 | 199.99 | 346.60 | 137.75 | 57.66 |
| Latest | 4.61 | 200.55 | 349.01 | 138.57 | 58.90 |
| Change | -0.08 | -0.66 | +0.79 | -1.20 | +1.01 |
| % Change | -1.71% | -0.33% | +0.23% | -0.86% | +1.74% |
| Volume | 297,421 | 1,038,232 | 984,801 | 1,819,814 | 3,840,234 |
| 20-Day Average Volume | 608,561 | 1,899,169 | 2,687,429 | 5,807,440 | 12,639,973 |
| Previous Close | 4.69 | 201.21 | 348.22 | 139.77 | 57.89 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.55 | 196.09 | 349.49 | 138.91 | 58.78 |
| 20-Day Raw Stochastic | 65.91% | 72.14% | 53.19% | 50.55% | 38.35% |
| 20-Day Relative Strength | 53.06 | 54.02 | 45.39 | 46.33 | 49.31 |
| Weighted Alpha | +28.97 | +46.53 | +24.28 | +31.25 | +24.01 |
| Today's Opinion | 40% Buy | 88% Buy | 24% Buy | 40% Buy | 48% Buy |
| Previous Opinion | 40% Buy | 88% Buy | 24% Buy | 56% Buy | 48% Buy |
| Last Month's Opinion | 24% Sell | 56% Buy | 80% Buy | 88% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.11% since 04/09/26 | -2.26% since 04/09/26 | -2.13% since 04/09/26 | -2.54% since 04/09/26 | -1.35% since 04/09/26 |
| Low | 4.43 on 04/10/26 | 199.49 on 04/15/26 | 344.21 on 04/15/26 | 137.02 on 04/13/26 | 57.22 on 04/15/26 |
| High | 4.70 on 04/15/26 | 207.30 on 04/10/26 | 357.46 on 04/10/26 | 142.38 on 04/10/26 | 59.80 on 04/10/26 |
| 1-Month | |||||
| %Chg | +11.99% since 03/16/26 | +4.35% since 03/16/26 | -4.97% since 03/16/26 | -4.63% since 03/16/26 | -1.75% since 03/16/26 |
| Low | 4.14 on 03/17/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 4.85 on 04/08/26 | 207.30 on 04/10/26 | 368.78 on 03/17/26 | 146.71 on 03/17/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -14.35% since 01/16/26 | +6.13% since 01/16/26 | +5.33% since 01/16/26 | +10.86% since 01/16/26 | +6.16% since 01/16/26 |
| Low | 3.95 on 03/13/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 122.28 on 01/20/26 | 53.54 on 01/21/26 |
| High | 5.70 on 01/22/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +15.05% since 10/16/25 | +19.50% since 10/16/25 | +17.65% since 10/16/25 | +17.51% since 10/16/25 | +35.20% since 10/16/25 |
| Low | 3.70 on 10/31/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 6.18 on 11/17/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 599,687 | 312,058,208 | 187,929,120 | 173,485,616 | 118,196,040 |
| Shares Outstanding, K | 127,865 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 201,490,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -66,540,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 62,140,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -44,080,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.28 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 02/26/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/14/26 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.31 | 16.06 | 17.23 | 9.44 |